The estimated Net Worth of Walter Phd Gilbert is at least $3.43 Миллион dollars as of 13 December 2019. Walter Gilbert owns over 5,860 units of Myriad Genetics stock worth over $1,423,062 and over the last 21 years he sold MYGN stock worth over $1,641,246. In addition, he makes $369,988 as Independent Vice Chairman of the Board at Myriad Genetics.
Walter has made over 14 trades of the Myriad Genetics stock since 2006, according to the Form 4 filled with the SEC. Most recently he bought 5,860 units of MYGN stock worth $150,016 on 13 December 2019.
The largest trade he's ever made was exercising 60,000 units of Myriad Genetics stock on 19 February 2014 worth over $1,288,800. On average, Walter trades about 11,541 units every 157 days since 2003. As of 13 December 2019 he still owns at least 54,150 units of Myriad Genetics stock.
You can see the complete history of Walter Gilbert stock trades at the bottom of the page.
Dr. Walter M. Gilbert Ph.D. is no longer serves as Independent Vice Chairman of the Board of the Company effective 12/2020. Dr. Gilbert won the Nobel Prize in Chemistry in 1980 for his contributions to the development of DNA sequencing technology. He was a founder of Biogen, Inc. and its Chairman of the Board and Chief Executive Officer from 1981 to 1985. Dr. Gilbert has held professorships at Harvard University in the departments of Physics, Biophysics, Biology, Biochemistry and Molecular Biology, and Molecular and Cellular Biology. He is a Carl M. Loeb University Professor Emeritus at Harvard University. . Gilbert founded and served on the Board of Directors of both Memory Pharmaceuticals Corp. and Paratek Pharmaceuticals, Inc. He also currently serves on the board of Amylyx Pharmaceuticals and is a General Partner of BioVentures Investors, an investment fund.
As the Independent Vice Chairman of the Board of Myriad Genetics, the total compensation of Walter Gilbert at Myriad Genetics is $369,988. There are 14 executives at Myriad Genetics getting paid more, with R. Bryan Riggsbee having the highest compensation of $3,138,980.
Walter Gilbert is 87, he's been the Independent Vice Chairman of the Board of Myriad Genetics since . There are no older and 26 younger executives at Myriad Genetics.
Walter's mailing address filed with the SEC is 320, Wakara Way, U of U Research Park, Salt Lake City, Salt Lake County, Utah, 84108, United States.
Over the last 22 years, insiders at Myriad Genetics have traded over $51,783,466 worth of Myriad Genetics stock and bought 61,160 units worth $1,252,955 . The most active insiders traders include Jerry S Lanchbury, Peter D Meldrum и Arthur H Jr Hayes. On average, Myriad Genetics executives and independent directors trade stock every 18 days with the average trade being worth of $563,312. The most recent stock trade was executed by Heinrich Dreismann on 9 September 2024, trading 10,000 units of MYGN stock currently worth $270,500.
myriad genetics inc., is a leading personalized medicine company dedicated to being a trusted advisor transforming patient lives worldwide with pioneering molecular diagnostics. myriad discovers and commercializes molecular diagnostic tests that: determine the risk of developing disease, accurately diagnose disease, assess the risk of disease progression, and guide treatment decisions across six major medical specialties where molecular diagnostics can significantly improve patient care and lower healthcare costs. myriad is focused on three strategic imperatives: maintaining leadership in an expanding hereditary cancer market, diversifying its product portfolio through the introduction of new products and increasing the revenue contribution from international markets. for more information on how myriad is making a difference, please visit the company's website: www.myriad.com.
Myriad Genetics executives and other stock owners filed with the SEC include: